Rate My Professor Matthew Doogue

Doogue's research interests centre on the quality use of medicines, encompassing medicines systems, adverse drug reactions, pharmacogenetics, applied pharmacokinetics, clinical decision support, and pharmacoinformatics. His expertise areas include adverse drug reactions, drug interactions, and quality use of medicines. The Clinical Pharmacology Research Group, of which he is a part, investigates clinical applications of pharmacology knowledge, including quality use of medicines using real-world data sets, clinical decision support in prescribing systems, adverse drug reactions, therapeutic drug monitoring, clinical pharmacology education, medicines information for patients, pharmacokinetic drug-drug interactions, phase III drug trials of gastroenterology drugs, and medicines in pregnancy and lactation. Key publications include: Pairman, L., Chin, P., & Doogue, M. (2026). Indication-based prescribing and prescribing with indications, effects on documentation, medicines use, and clinical outcomes: A systematic review. International Journal of Medical Informatics, 207, 106209; Chin, P. K. L., & Doogue, M. P. (2025). Oral anticoagulation for adults with atrial fibrillation or venous thromboembolism. Australian Prescriber, 48(5), 161-166; Sundermann, M. et al. (2025). Antibiotic prescribing for cellulitis in the absence of penicillin-cephalosporin cross-reactivity alerts: A retrospective study. Pharmacology Research & Perspectives, 13(5), e70175; Newman, N. et al. (2025). Consent to medical student teaching: An observational, cross-sectional study exploring the patient view. Proceedings of the 10th International Clinical Skills Conference.